Date Published: 3 November 2015
CNPLaw LLP (“CNP”), formerly known as Colin Ng & Partners LLP, acted as Singapore counsel for Link Healthcare (“Link“), a specialist pharmaceutical and medical technology business focussed on the Asian, African and Australasian (“AAA“) regions, on the sale of Link to Clinigen Group plc (“Clinigen“), the speciality global pharmaceutical company listed in the UK, for an initial consideration of £44.5 million and a maximum of approximately £100 million based on achievement of milestones.
Clinigen agreed to acquire Link in late September 2015 and the acquisition was completed on 30 October 2015.
CNPLaw’s Mergers and Acquisitions Lawyers
Bill is an English lawyer who is also registered to practise Singapore law and he is recognised by professional and commercial publications. According to Chambers and Partners, Bill is “experienced in providing regulatory advice and drafting fund documentation.” For 2020, investment funds, IFLR1000 has rated him as “Highly Regarded” and Asialaw Leading Lawyers has ranked him as a “Distinguished practitioner”. Bill is also recommended by The Legal 500 Asia Pacific 2020 for the Investment Funds practice.
Amit’s practice focuses on corporate law, investment funds, mergers and acquisitions and regulatory and compliance matters. He has over 15 years’ experience in these areas of law. Amit’s expertise has been recognised in Legal 500 Asia Pacific, 2020 as “Recommended Lawyer for Corporate and M&A as well as Investment Funds”. In December 2016, Amit was named by Singapore Business Review as one of the 70 most influential lawyers in Singapore under the age of 40.